Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

Launched by THE INSTITUTE OF MOLECULAR AND TRANSLATIONAL MEDICINE, CZECH REPUBLIC · Jul 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying new ways to diagnose and monitor brain tumors, specifically a type called glioblastoma (GBM). Researchers want to find out if they can detect tiny pieces of tumors in the blood and urine of patients and how these tests can help understand the disease better. By looking at different markers in the blood, including proteins and genetic material, the study hopes to learn how well treatments are working, if the tumor is growing, and if it is resistant to therapy.

To participate in this trial, you must be an adult with a diagnosed brain tumor, and you cannot have any other cancers or inflammatory diseases. The trial is currently recruiting participants, and if you join, you can expect to have your blood and urine tested at different times: before your surgery and again three months after. This research could lead to better ways to monitor brain tumors and improve treatment options in the future.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Adult patients with brain tumors -
• • Exclusion Criteria: No other cancer; no inflammatory disease
• • -